1. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
- Author
-
Ramanathan, S, Mohammad, S, Tantsis, E, Nguyen, Tk, Merheb, V, Fung, Vsc, White, Ob, Broadley, S, Lechner-Scott, J, Vucic, S, Henderson, Apd, Barnett, Mh, Reddel, Sw, Brilot, F, Dale, Rc, Australasian and New Zealand MOG Study Group Andrews, P, Barton, J, Burrow, J, Butzkueven, H, Cairns, A, Calvert, S, Caruana, P, Chelakkadan, S, Clark, D, Fraser, C, Freeman, J, Gill, D, Grattan-Smith, P, Gupta, S, Hardy, T, Kothur, K, Ling, S, Lopez, J, Malone, S, Marriott, M, Nosadini, M, O'Grady, G, Orr, C, Ouvrier, R, Parratt, J, Patrick, E, Pilli, D, Riminton, D, Riney, K, Rodriguez-Casero, V, Ryan, M, Scheffer, I, Shah, U, Shuey, N, Spooner, C, Subramanian, G, Tea, F, Thomas, T, Thompson, J, Troedson, C, Ware, T, Webster, R, Yiannikas, C, Yiu, E, and Zou, A.
- Subjects
Male ,0301 basic medicine ,Journal Club ,medicine.medical_treatment ,Demyelinating Autoimmune Diseases, CNS ,Cohort Studies ,0302 clinical medicine ,Prednisone ,Child ,10. No inequality ,MOG antibody, demyelination, treatment ,treatment ,biology ,Encephalomyelitis, Acute Disseminated ,Neuromyelitis Optica ,Brain ,Immunoglobulins, Intravenous ,Middle Aged ,Magnetic Resonance Imaging ,3. Good health ,Psychiatry and Mental health ,Child, Preschool ,Acute disseminated encephalomyelitis ,Cohort ,Female ,demyelination ,Immunotherapy ,Antibody ,Rituximab ,Immunosuppressive Agents ,medicine.drug ,MOG antibody ,Adult ,medicine.medical_specialty ,Optic Neuritis ,Adolescent ,Myelitis, Transverse ,Myelin oligodendrocyte glycoprotein ,Young Adult ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,Immunologic Factors ,Optic neuritis ,Aged ,Autoantibodies ,Expanded Disability Status Scale ,business.industry ,Infant ,Mycophenolic Acid ,medicine.disease ,030104 developmental biology ,Immunology ,biology.protein ,Myelin-Oligodendrocyte Glycoprotein ,Surgery ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
ObjectiveWe characterised the clinical course, treatment and outcomes in 59 patients with relapsing myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination.MethodsWe evaluated clinical phenotypes, annualised relapse rates (ARR) prior and on immunotherapy and Expanded Disability Status Scale (EDSS), in 218 demyelinating episodes from 33 paediatric and 26 adult patients.ResultsThe most common initial presentation in the cohort was optic neuritis (ON) in 54% (bilateral (BON) 32%, unilateral (UON) 22%), followed by acute disseminated encephalomyelitis (ADEM) (20%), which occurred exclusively in children. ON was the dominant phenotype (UON 35%, BON 19%) of all clinical episodes. 109/226 (48%) MRIs had no brain lesions. Patients were steroid responsive, but 70% of episodes treated with oral prednisone relapsed, particularly at doses ConclusionRelapsing MOG antibody-associated demyelination is strongly associated with ON across all age groups and ADEM in children. Patients are highly responsive to steroids, but vulnerable to relapse on steroid reduction and cessation.
- Published
- 2017
- Full Text
- View/download PDF